MYMD PHARMACEUTICALS INC's ticker is and the CUSIP is 62856X102. A total of 45 filers reported holding MYMD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $27,000 | – | 10,492 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Shay Capital LLC | 309,178 | $671,000 | 0.14% |
Taylor & Morgan Wealth Management, LLC | 17,086 | $37,000 | 0.04% |
Ikarian Capital, LLC | 81,089 | $176,000 | 0.03% |
Corundum Group, Inc. | 19,600 | $43,000 | 0.03% |
M Holdings Securities, Inc. | 70,909 | $154,000 | 0.02% |
Praetorian Wealth Management, Inc. | 15,000 | $32,000 | 0.01% |
Western Wealth Management, LLC | 27,050 | $115,000 | 0.01% |
Mirae Asset Global Investments Co., Ltd. | 1,073,765 | $2,330,000 | 0.01% |
Virtu Financial LLC | 16,063 | $35,000 | 0.00% |
SeaCrest Wealth Management, LLC | 6,800 | $15,000 | 0.00% |